Home
Home » companies

JNJ

J&J builds 9-month supply of Doxil with creative problem solving

J&J builds 9-month supply of Doxil with creative problem solving
Fierce Pharma

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Motley Fool

Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?

Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Motley Fool

Drugmakers to share neglected compounds with British academia

Drugmakers to share neglected compounds with British academia
Yahoo/Reuters

Johnson & Johnson sets $5 billion share buyback

Johnson & Johnson sets $5 billion share buyback
Marketwatch

It’s a Good Time to Be a Drugmaker: Why J&J Is Beating Wall Street

It’s a Good Time to Be a Drugmaker: Why J&J Is Beating Wall Street
Wall St Cheat Sheet

J&J's new fixer turns consumer division back into a profit center

J&J's new fixer turns consumer division back into a profit center
Fierce Pharma

[video] Turnaround: What Was Fixed at Johnson & Johnson?

[video] Turnaround: What Was Fixed at Johnson & Johnson?
Bloomberg

J&J 2Q profit climbs 13 percent on new-drug sales

J&J 2Q profit climbs 13 percent on new-drug sales
Yahoo/AP

Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong

Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong
Seeking Alpha